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Developing a mechanistic understanding of the impact of food structure and composition on human health has
increasingly involved simulating digestion in the upper gastrointestinal tract. These simulations have used a wide range of
different conditions that often have very little physiological relevance, and this impedes the meaningful comparison of
results. The standardized protocol presented here is based on an international consensus developed by the COST
INFOGEST network. The method is designed to be used with standard laboratory equipment and requires limited
experience to encourage a wide range of researchers to adopt it. It is a static digestion method that uses constant ratios of
meal to digestive fluids and a constant pH for each step of digestion. This makes the method simple to use but not
suitable for simulating digestion kinetics. Using this method, food samples are subjected to sequential oral, gastric and
intestinal digestion while parameters such as electrolytes, enzymes, bile, dilution, pH and time of digestion are based on
available physiological data. This amended and improved digestion method (INFOGEST 2.0) avoids challenges associated
with the original method, such as the inclusion of the oral phase and the use of gastric lipase. The method can be used to
assess the endpoints resulting from digestion of foods by analyzing the digestion products (e.g., peptides/amino acids,
fatty acids, simple sugars) and evaluating the release of micronutrients from the food matrix. The whole protocol can be
completed in ~7 d, including ~5 d required for the determination of enzyme activities.
Introduction
The worldwide prevalence of diet-related diseases has been on the increase for the past few decades1.
Large-scale human intervention trials have been used to correlate diet with the health of different
demographic groups. However, to understand the physiological response to specific foods, it is
necessary to follow the complex digestive processes within the human digestive tract in more detail.
This can be achieved with invasive procedures, such as aspiration from the stomach2 or small
intestine3 or with less invasive imaging technologies (e.g., magnetic resonance imaging4) and wireless
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telemetric systems2,5. Animal models are also widely used, although their use generally involves
animal death or surgical approaches in which cannulas are placed into digestive organs to access the
contents of the gastrointestinal tract. The relevance of animal models for understanding food
digestion in humans is also regularly questioned. In summary, in vivo (human or animal) inter-
vention trials can be difficult to undertake, unsuitable and expensive or are not justifiable on ethical
grounds. For these reasons, in vitro models have been used for many decades to simulate the
digestion of food.
Development of the protocol
There are several types of in vitro digestion methods that are commonly used for food; these can be
divided into static and dynamic methods. These models aim to simulate the physiological conditions
of the upper gastrointestinal tract, namely the oral, gastric and small intestinal phases. Most dynamic
models6–10 have been shown to be suitable for simulating the digestion of foods and pharmaceutical
products in different population groups and for different purposes11. However, these models are
relatively complex, expensive to set up and maintain, and therefore may not be available to the
majority of food researchers.
Owing to its simplicity, static models, which use a constant ratio of food to enzymes and elec-
trolytes, and a constant pH for each digestive phase, have been widely used for many decades for food,
animal feed and pharmaceutical purposes12–14. Static in vitro digestion models have been shown to be
very useful in predicting outcomes of in vivo digestion15,16. There are standardized static models17 that
vary in complexity18,19; these are used for simulating the gastrointestinal behavior of pharmaceutical
products (United States Pharmacopeia methods)17. Other static methods were developed for assessing
the in vitro bioaccessibility of soil contaminants20, heavy metals in particular, or mycotoxins in food21.
These methods, developed and standardized22 by the Bioaccessibility Research Group of Europe
(BARGE) were based on available physiological data reported by landmark papers such as Dressman
et al.23 or the Geigy tables24. The static methods of the BARGE group and United States Pharmacopeia
procedures were important milestones in the evolution of standardized in vitro digestion methods.
However, their experimental conditions, purpose and endpoints were found to be unsuitable for
digesting food because of the complexity and variability of food structures, as well as very different
research questions in food science. This resulted in the use of a great number of digestion methods,
reviewed by Hur et al.25, with slight but important variations in parameters such as pH, duration,
enzyme concentration and activity, and composition of simulated digestive fluids.
Hence, the need for a harmonization of digestion conditions was identified, and the international
INFOGEST26 network (http://www.cost-infogest.eu) of multidisciplinary experts (in, e.g., food sci-
ence, nutrition, gastroenterology, engineering and enzymology) from more than 35 countries was
established. One of the primary outcomes of this network was an international consensus on a set of
digestion parameters for a static in vitro simulation of adult digestion suitable for food. The method,
generally referred to as the INFOGEST method, was published27, and experimental parameters were
justified and discussed in great detail in relation to available in vivo physiological data. Some of the
previous digestion methods outlined above were used as a starting point. Since its publication in 2014,
this in vitro digestion method has received a Highly Cited Paper status for agricultural sciences, with
more than 650 citations in Web of Science and has been extensively used all over the world for
numerous purposes, with a variety of foods and different endpoints. The current article builds on that
publication and clarifies a number of aspects of the original protocol, leading to an improved
INFOGEST 2.0 protocol, which is described here.
Overview of the procedure
The digestion procedure is summarized in Fig. 1. It can be divided into three phases: preparation,
digestion procedure and sample treatment with subsequent analysis. For preparation of the in vitro
digestion, the activities of all digestive enzymes and the concentrations of bile salts should be
determined experimentally, using the recommended standardized assays for amylase, pepsin, lipase
(both gastric and pancreatic), trypsin and chymotrypsin, outlined in Box 1 and described in detail in
the Supplementary Information, based on Minekus et al.27. This first preparation step is of the utmost
importance, and failure to correctly assay enzyme activity will lead to incorrect rates of digestion of
components (e.g., proteins)28, potentially changing the overall digestion of the food.
The digestion involves the exposure of the food to three successive digestive phases: oral, gastric
and intestinal. For static in vitro digestion methods, the experimental conditions are constant during
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each phase. The oral phase involves dilution of the food 1:1 (wt/wt) with simulated salivary fluid
(SSF), with or without salivary amylase, and for solids or semisolids, simulated mastication of the
food. If used, exposure of the food to salivary amylase is limited to 2 min at pH 7. The oral phase
must be included in all simulated digestion procedures, regardless of the state of the food (liquid or
solid) in order to provide consistency of dilution. Further clarification regarding the preparation of
the food and the oral phase can be found in the ‘Experimental design’ section.
The oral bolus is then diluted 1:1 (vol/vol) with simulated gastric fluid (SGF) and gastric enzymes
(pepsin and gastric lipase) and incubated under agitation at pH 3.0 for 2 h. The gastric chyme is then
diluted 1:1 (vol/vol) with simulated intestinal fluid (SIF), bile salts and pancreatic enzymes
(pancreatin based on the activity of trypsin or as individual enzymes) and incubated at pH 7 for a
further 2 h.
The experimental conditions for the digestion procedure, such as pH, time of digestion and
enzyme activity, were based on available physiological data of the fed state for a typical meal and were
described and justified in detail in Minekus et al.27. For this improved INFOGEST 2.0 method, the use
of gastric lipase is recommended; hence, a detailed justification of the type and activity of the gastric
lipase is provided in the ‘Experimental design’ section.
The last step of the digestion procedure involves sampling, sample treatment, storage and sub-
sequent analysis of samples. This step should be carefully considered before digestion, as it may differ
from case to case because of different endpoints, purposes of the digestion experiment and type
of analysis. A description of sample treatment can be found in the ‘Experimental design’ section
and Table 1.
Advantages and limitations
Static in vitro digestions are the simplest methods for simulation of in vivo food digestion. Although
there are clear weaknesses in these simple models, they have obvious advantages over more complex
methods. The main strengths of static in vitro models are the good intra- and inter-laboratory
reproducibility, robustness, simplicity, relatively low cost and easy assessment of each digestion phase.
This latter point makes them quite suitable for mechanistic studies, hypothesis building and
screening. It was one of the aims of the INFOGEST network to not only standardize in vitro methods
but to agree on experimental conditions based on available physiological data that are as close as
possible to the in vivo equivalent, while keeping the method sufficiently simple to reproduce all over
the world. The clear definition of standardized experimental conditions and procedures is one
of the major advantages of the INFOGEST method. Egger et al.28 showed very good lab-to-lab
• Perform enzyme activity and bile assays 1
• Prepare SSF, SGF and SIF stock solutions 2
• Perform pH-test adjustment experiment 4
• Sampling procedure and sample
  treatment (Table 1)
• Mix Food with SSF (1:1, (wt/wt)) 7–12
• Include CaCl2 (1.5 mM in SSF) 13
• Add salivary amylase, if necessary (75 U/mL) 14
• Incubate while mixing (2 min, 37 °C, pH 7) 15, 16
• Mix oral bolus with SGF (1:1 (vol/vol)) 17, 18
19
• Add pepsin, gastric lipase (2,000, 60 U/mL) 20, 21
• Incubate while mixing (2 h, 37 °C, pH 3.0) 22–24
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Fig. 1 | Flow diagram of the INFOGEST 2.0 digestion method. Timing and flow diagram of the INFOGEST 2.0 in vitro
digestion method for food. Expected time frame (left) and stages and corresponding step numbers in the Procedure
(right) are given. SGF, simulated gastric fluid; SIF, simulated intestinal fluid; SSF, simulated salivary fluid.
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reproducibility of results with regard to peptide patterns from the in vitro digestion of skim milk from
powder. Some weaknesses were identified and subsequently addressed. The recommendation of
standardized enzyme assays (including units) substantially added to the precision and reproducibility
of the digestion procedure, as previously a number of common but slightly different enzyme assays
were being used, resulting in the application of a wide range of enzyme activities during digestion
experiments. The endpoint of this INFOGEST method was recently compared to digests obtained in
human jejunum after casein and whey protein ingestion16 and showed excellent correlation of protein
degradation and peptide patterns, as explained below in the ‘Applications’ section.
However, static digestion methods have known limitations and cannot mimic the complex
dynamics of the digestion process or the physiological interactions with the host. For example, for the
gastric phase, the pH is kept constant, and there is a lack of the gradual addition of gastric fluid (acid,
minerals and pepsin) and an absence of gradual gastric emptying. In addition, the enzyme activity in
each digestive phase is kept constant, regardless of the type of food and whether the food contains
high or low amounts of substrate, e.g., proteins, lipids and carbohydrates. The intestinal phase is
treated as one phase rather than as the sequential duodenal, jejunal and ileal phases, which exhibit
different dilutions, mineral content, pH, enzyme activities and microbial content. These shortcomings
render the method unsuitable for detailed kinetic analysis of the different stages of the digestion
process. However, in vivo comparison shows good correlation with the INFOGEST method at the
Box 1 | Enzyme activity assays
Detailed assays are given in the Supplementary Methods for each enzyme and are based on Minekus et al.27.
Pepsin activity assay
Principle: hemoglobin plus H2O produces TCA-soluble tyrosine peptides when pepsin is applied.
Unit definition: one unit produces a ΔA280 of 0.001 per min at pH 2.0 and 37 °C, measured as TCA–soluble
products.
Substrate: 2% (wt/vol) hemoglobin in water at pH 2.
Enzyme solution: pepsin in 10 mM Tris buffer, 150 mM NaCl, pH 6.5. Before the assay, dilute it in 10 mM HCl at
concentrations ranging from 5 to 30 µg/mL.
Mix 500 µL of hemoglobin with 100 µL of each pepsin solution (5–30 µg/mL) and incubate for 10 min at 37 °C.
To stop the reaction, add 1 mL of 5% (wt/vol) TCA. Centrifuge at 6,000g for 30 min at room temperature and
read the absorbance at 280 nm in quartz cuvettes.
Lipase activity assay
Principle: tributyrin plus H2O produces butyric acid and sn-2 monobutyrin when lipase is applied.
Unit definition: one unit releases 1 µmol of butyric acid per min at 37 °C at the pH of the assay.
Substrate: tributyrin purity ≥99%.
Enzyme solution: Lipase 1 mg/mL in H2O.
Assay solution for gastric lipase: 2 mM sodium taurodeoxycholate, 150 mM NaCl and 1 μM BSA.
Assay solution for pancreatic lipase: 4 mM sodium taurodeoxycholate, 150 mM NaCl and 1.4 mM CaCl2(H2O)2.
In a pH-stat at 37 °C, mix 14.5 mL of assay solution with 0.5 mL of tributyrin, and stir until it forms a fine oil-in-
water emulsion. Add 50 or 100 µL of enzyme solution (1 mg/mL) and monitor the rate of titrant (0.1 N NaOH) to
maintain pH 6.0 (human gastric lipase), pH 5.5 (rabbit gastric lipase) or pH 8 (pancreatic lipase) for 5 min.
Trypsin activity assay
Principle: TAME plus H2O produces p-toluene-sulfonyl-L-arginine plus methanol when trypsin is applied.
Unit definition: One unit hydrolyzes 1 μmol of p-toluene-sulfonyl-L-arginine methyl ester (TAME) per min at pH
8.1 and 25 °C.
Substrate: 10 mM TAME in H2O.
Enzyme solution: Trypsin in 1 mM HCl at concentrations ranging from 10 to 20 µg/mL.
Mix 2.6 mL of 46 mM Tris–HCl buffer (pH 8.1) with 300 µL of the substrate at 25 °C. Add 100 µL of each trypsin
assay solution. Read the absorbance increase at 247 nm during 10 min.
Amylase activity assay
Principle: Starch plus H2O produces reducing groups (e.g., maltose) when α-amylase is applied.
Unit definition: One unit releases 1.0 mg of maltose equivalent from starch in 3 min at pH 6.9 and 20 °C.
Substrate: 1.0 % (wt/vol) soluble potato starch in 20 mM sodium phosphate buffer with 6.7 mM NaCl, adjusted
to pH 6.9.
Enzyme solution: 1 mg/mL amylase in H2O.
Incubate 1 mL of substrate at 20 °C, add the enzyme solution (0.5–1 mL, with an estimated activity of 1 unit/mL)
and incubate at 20 °C for 3 min. Stop the reaction with a color reagent (96 mM 3,5-dinitrosalicyclic acid, 5.3 M
sodium potassium tartrate). Bring the volume to 1 mL with H2O, cap the tube and boil for 15 min. Add 9 mL of
H2O and read the absorbance at 540 nm. Calculate the activity against a maltose standard curve.
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endpoints of each digestion phase16,29. For this reason, the static model should be used only to assess
digestion endpoints and not kinetics.
In some cases, a slight alteration of the procedure can be considered to more accurately reflect
physiological conditions. For example, during the gastric in vivo digestion of food containing pro-
biotic bacteria, the bacteria are exposed to a range of pH values, which can be as low as 1 at the end of
the gastric emptying. Hence, a static method with a constant pH of 3.0 for the gastric phase may fail
to accurately predict probiotic survival, and a lower pH or a dynamic gastric model should be chosen.
In the study of the bioaccessibility of phytochemicals such as polyphenols and carotenoids, the model
allows the realistic release from a food into the aqueous phase. However, specific hydrolytic processes
occurring at the brush border are currently not simulated, and additional steps, such as centrifugation
of the digesta, are needed to separate the bioaccessible phases. An extension including colonic
fermentation, an important step in the bioactivation of several phytochemicals, would further
enhance the physiological appropriateness. Finally, for the assessment of the bioaccessibility of small
amounts of contaminants in food, such as heavy metals, environmental pollutants or mycotoxins,
alternative methods reflecting extensive digestion and worst-case scenarios20 can be applied.
Applications
The method described has been used to assess the release of carotenoids and phenolic compounds
from different matrices, such as carotenoids in fruits30,31, carotenoids in tomatoes compared to
tomatoes subjected to pulsed electric fields32, β-carotene protected by microencapsulation33 and
resveratrol encapsulated in protein nanoparticles34. However, most studies have been dedicated to the
evaluation of protein, lipid and starch digestion in foods or modified carriers. Protein digestion has
been widely assessed in different dairy products35,36 and in isolated milk proteins, such as lactoferrin,
with different iron contents and after mild heat treatment37. The stability of proteins to gastro-
intestinal digestion has been proposed as an additional piece of information for the allergenicity
assessment of novel proteins38. With this focus, the INFOGEST method was also applied to the study
of the immunogenic potential of peptides from pasta39, hazelnut40 and peanut41, which are resistant
to gastrointestinal digestion. Using a pH-stat to monitor enzymatic hydrolysis, it was shown that solid
emulsions led to a lesser extent of lipolysis but a greater degree of proteolysis as compared to liquid
emulsions because of the higher sensitivity of denatured whey proteins to gastrointestinal enzymes42.
The tendency of dairy rennet gels to form compact protein aggregates during gastric digestion has
also been assessed43. Other applications of this protocol include the evaluation of novel biopolymers
designed for a controlled nutrient release44,45 and the digestive stability of transgenic microRNAs in
genetically modified plants46.
An inter-laboratory trial applying different in vitro digestion protocols clearly demonstrated a
good reproducibility obtained by using the standardized INFOGEST protocol. It also highlighted the
importance of correctly applying standardized pepsin activity assays, which is a key factor for proper
gastric protein hydrolysis28. A special effort was made to validate and compare the results from this
in vitro digestion protocol with in vivo data. For instance, β-cryptoxanthin bioavailability of pas-
teurized orange juice was found to be higher than that of fresh oranges in a randomized crossover
human study, and from the in vitro digestion an increased bioaccessibility could also be inferred47.
Several studies have focused on protein digestion and the comparison with in vivo digestion in
human or animal models. The results from the in vitro gastrointestinal digestion of skim milk powder
were compared with in vivo porcine samples collected from the stomach and several sites in the
intestine29. Protein degradation and peptides generated at the end of the gastric phase correlated well
with in vivo gastric peptides, and the in vitro intestinal phase correlated well with the in vivo samples
taken in the median jejunum. Human jejunal digests after the oral ingestion of casein and whey
protein were compared with the intestinal digests obtained using the standardized INFOGEST
method16. In vivo and in vitro intestinal digests showed common protein regions that are resistant to
digestion and a high number of identical peptide sequences, and the researchers concluded that the
INFOGEST in vitro method is a good approximation of the endpoints of gastrointestinal digestion of
milk proteins in vivo.
Alternative methods
A wide variety of static in vitro digestion models can be found in the literature25, but they all exhibit
different conditions (e.g., pH, duration of each step, ratio of enzymes to substrate), making the
comparison between studies impossible. The static methods published by Versantvoort et al.21,
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Garrett et al.48 and Oomen et al.20 are among the most highly cited approaches. However, most of the
static in vitro digestion methods found in the literature simulate the fasted state, which is quite far
from the physiological conditions when food is digested in the gastrointestinal tract. The advantages
and limitations of static in vitro digestion models were recently reviewed by a group of experts within
the INFOGEST network15. Although static methods can be useful for understanding trends or
performing a screening of samples, they fall short in their ability to assess some of the important
dynamic processes occurring during gastrointestinal digestion, namely the pH gradients and the
gradual addition of enzymes and gastric fluid, as well as continuous gastric emptying. More phy-
siologically relevant dynamic digestion methods6–10 take these and other factors into account.
However, these models are highly complex, require substantial hardware and software and are still
expensive to set up and maintain; hence, they are often not available to food researchers. It has
recently been shown that, when human data are available to set up the system, these models can be
physiologically relevant11. In an effort to improve in vitro digestion methods, a low-cost semi-
dynamic method was recently developed49 and described in detail50, in which parameters were based
on the equivalent in vivo data from the digestion of dairy products. Here, the SGF and pepsin are
slowly added to the food in a suitable reaction vessel with manual, stepwise gastric emptying. A
harmonization of experimental conditions is currently ongoing, and a standardized semi-dynamic
method will be published in 2019 by INFOGEST members, coordinated by A.R. Mackie.
Even though they are expensive and must be ethically justifiable, in vivo models have been widely
used for studying the digestive process. The pig model can closely simulate the upper part of the
human digestive tract (stomach and small intestine)51. Conventional pigs or mini-pigs can be used for
this purpose and can be equipped with cannulas, in order to allow sampling of the effluents
throughout digestion, and a catheter to collect blood, whereas piglets can be used for all the questions
related to neonatal nutrition29,52,53.
Finally, human volunteers can be equipped with naso-gastric or naso-intestinal probes to
access and sample digestive effluents3. Ileostomy patients have been used to study digestion54–56
but can hardly be considered as models of a healthy human because they are affected by
digestive pathologies.
Experimental design
Enzyme assays
The determination of the standard units of activity of the enzyme used in the protocol is a critical step
and one of the main sources of variation in results between different laboratories37.
Enzyme activity determination is recommended for each new batch of enzyme or after
prolonged storage.
Enzyme and bile assays were previously described in protocol format in the supplementary
materials of Minekus et al.27, namely α-amylase (EC 3.2.1.1), pepsin (EC 3.4.23.1), trypsin (EC
3.4.21.4), chymotrypsin (EC 3.4.21.1), pancreatic lipase (EC 3.1.1.3) and bile salts (according to
supplier’s protocol). To improve the reproducibility of the pepsin activity assay for this revised
INFOGEST 2.0 protocol, it is now recommended to dissolve pepsin in 10 mM Tris buffer (tris-
hydroxymethyl-aminomethane), 150 mM NaCl (pH 6.5), instead of in sodium chloride solution
adjusted with sodium hydroxide. The buffering capacity of Tris buffer reduces the variability in the
measurement of the pepsin activity, as shown previously37. The detailed protocols for the complete
set of enzyme and bile assays, including that of the gastric lipase assay (EC 3.1.1.3), can be found in
the Supplementary Methods and are summarized in Box 1.
Spreadsheets for the enzyme assays and the volumes for the digestion procedure are provided in
Supplementary Data 1 and 2. The enzyme assay spreadsheets (Supplementary Data 1) can be used to
calculate the enzyme activities of all digestive enzymes. The digestion spreadsheets (Supplementary
Data 2) provide help in calculating all volumes of simulated digestive fluids, enzyme and bile solu-
tions on the basis of the initial amount of digested food; one example is shown in Table 2. The
corresponding online spreadsheets can also be used, and are available at http://www.proteomics.ch/
IVD and on the INFOGEST website https://www.cost-infogest.eu/. In addition, videos of
the digestion procedures (Supplementary Videos 1 and 2) and all enzyme activity assays
(Supplementary Videos 3 to 7) are available in the Supplementary Information. The videos are also
available online on the YouTube channel ‘In vitro food digestion - COST action INFOGEST’
(https://www.youtube.com/channel/UCdc-NPx9kTDGyH_kZCgpQWg) and on the INFOGEST
website (https://www.cost-infogest.eu/).
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Food preparation and oral phase
It is important to plan the preparation of the food and the oral phase before in vitro gastrointestinal
digestion to determine the food to digestive enzyme ratio throughout the in vitro digestion process.
First, consideration should be given as to whether the food to be digested in vitro is consumed as a
meal, a meal portion or even a food ingredient. Some foods, such as milk, are often consumed on
their own or as part of a meal. Other foods or food ingredients are nearly always consumed as part of
a meal rather than on their own (e.g., coconut milk, spices, pure proteins and oils). Hence, these foods
should be prepared in a way that reflects real food or a meal, e.g., dilution, emulsification, integration
into other foods. High-solid foods such as powders must be reconstituted in liquids to make them a
consumable food.
An optional oral phase with a standardized 1:1 (wt/wt) ratio of food to simulated oral fluid for all
foods (solid and liquid foods) was recommended by the INFOGEST method27 in 2014. Although
in vivo data vary greatly (Supplementary Fig. 1), this dilution ratio enables the formation of a
swallowable bolus with almost all types of foods. For this revised INFOGEST 2.0 protocol, a stan-
dardized, easy-to-follow approach for the oral phase is necessary. Hence, it is now recommended to
dilute all food 1:1 (wt/wt) with simulated oral fluid to achieve a swallowable bolus with a paste-like
consistency that is no thicker than that of tomato paste or mustard at the end of the oral phase. If the
consistency of the bolus is thicker than such a paste, add water to achieve the proper consistency (see
also Table 2 and the ‘Troubleshooting’ section).
Use of lipase in the gastric phase
Lipid digestion starts in the stomach with the action of preduodenal lipase (gastric lipase in humans;
lingual lipase in rodents) on triacylglycerides (TAGs) and some other esters57. Gastric lipolysis not
only contributes to the overall digestion of TAGs (10% with a solid–liquid test meal to 25% with an
emulsified liquid test meal) but it also triggers the subsequent action of pancreatic lipase on lipid
substrates that may be poorly digested by pancreatic lipase alone; examples include milk fat droplets
and lecithin-stabilized TAG emulsions58. It is therefore recommended to add gastric lipase during the
gastric phase of in vitro digestion. The mean gastric lipase concentration in human gastric juice is
100 µg/mL, which is equivalent to 120 U/mL, using tributyrin as the reference substrate for gastric
lipase59,60. In some static digestion models, a concentration of ~16 µg of gastric lipase/mL (20 U/mL)
Table 2 | Example of an in vitro digestion experiment with 5 g of food
Input 5 g of liquid or solid food
Digestion phase Oral (SSF) Gastric (SGF) Intestinal (SIF)
Food or digesta 5 g of food 10 mL from oral phase 20 mL from gastric phase
1.25× electrolyte stock solutions (mL) 4a 8 8b
CaCl2(H2O)2 (0.3 M) (mL) 0.025 0.005 0.04
Enzymes Salivary amylasec Pepsin Gastric lipased Trypsin in
pancreatin
Bile salts
Enzyme activity (U/mL) or bile concentration
(mM) in total digesta (final volume in milliliters
at each digestion phase, see row below)
75 U/mL 2,000 U/mL 60 U/mL 100 U/mL 10 mM
Specific activitye (U/mg), concentration (bile)
mmol/g
100 U/mg 3,000 U/mg 25 U/mg 6 U/mg 0.667
mmol/g
Concentration of enzyme/bile solution (mg/mL) 10 20 100 133.3 200
Volume of enzyme/bile to be added (mL) 0.75 0.667 0.48 5b 3b
H2O (mL) 0.225 0.448 3.16
HCl (5 M) for pH adj. (mL) – 0.4 –
NaOH (5 M) for pH adj. (mL) – – 0.8
Final volume (mL) 10 20 40
a1:1 (wt/wt) dilution with simulated salivary fluid (SSF) should result in a paste-like consistency; add more water if necessary. Some foods may not be digested as expected due to a high substrate-
to-enzyme ratio in the static digestion method and may need to be further diluted with water before the oral phase; see Table 4. bTotal volume of simulated intestinal fluid (SIF 1.25×): 16 mL,
including pancreatin (5 mL) and bile (3 mL), both of which are dissolved in SIF. cUse salivary amylase only for food containing starch. dRabbit gastric extract (RGE) contains gastric lipase and pepsin,
i.e., the pepsin content needs to be accounted for in the total pepsin activity. eSpecific enzyme activity or bile concentration: measured for each batch of enzymes or bile extract according to
standard assays (see Box 1 and Supplementary Information).
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has been used to reproduce gastric conditions at the halfway point of gastric emptying61,62,
which corresponds to a gastric juice to meal ratio of 1:5 (vol/vol). In the INFOGEST method,
the gastric phase of digestion includes a 1:1 dilution of the oral bolus with SGF, which would
correspond to a dilution of gastric juice by half and thus a gastric lipase concentration of 60 U/mL. To
date, access to commercially available gastric lipase or an appropriate equivalent has been limited;
hence, gastric lipase has been omitted or lipases from alternative sources have been widely used.
However, caution should be applied regarding the specific biochemical properties of these alternative
lipases. Human gastric lipase (HGL), encoded by the LIPF gene, is stable and active between pH 2 and
7, with an optimal activity between pH 4 and 5.4. HGL displays an SN3 stereospecificity for
TAG hydrolysis (where SN defines stereospecific numbering in positions 3 of the triglycerol moiety),
leading to the preferential release of short/medium-chain fatty acids from milk TAGs61. It is resistant
to pepsin hydrolysis and is not inhibited by bile salts. HGL can, however, be replaced by other
preduodenal lipases from the acid lipase gene family of various mammalian species such as dog63
and rabbit64. Rabbit gastric lipase is now commercially available (Lipolytech, http://www.lipolytech.
com). Preduodenal lipases originating from the oropharyngeal tissues of young ruminants
(pharyngeal lipase of calf, kid goat and lamb) may also be used and are commercially available for
applications in the dairy industry (DSM for Capalase K and Capalase KL lipases; CHR Hansen
for Lipase Kid-Goat ST20, Lipase Calf 57 LFU, Spice IT AC and Spice IT AG; DuPont Danisco,
Clerici-Sacco). These preduodenal lipases are, however, less resistant to acid denaturation
(threshold at around pH 3.5 (ref. 65)) than gastric lipase, and pH conditions may have to be adapted.
Their contents and activity should be estimated before use in in vitro digestion experiments, using the
recommended standard gastric lipase assay27; see the Supplementary Information. So far, no
commercially available lipase of microbial origin combines all the above properties of gastric
lipase61,66, and their use is not recommended at this time. For this revised INFOGEST 2.0 protocol,
the authors recommend using rabbit gastric lipase, commercially available as rabbit gastric extracts
(RGEs), at 60 U/mL in the final gastric digestion mixture. However, because these extracts also
contain pepsin67, the pepsin concentration/activity in the gastric phase must be accordingly adjusted
to the recommended value.
Sampling, controls and test tube
Before performing the protocol (time-lagged before the digestion experiment or 1 d before the
digestion experiment), it is recommended to run one preliminary experiment, the pH-test adjustment
experiment, with the relevant amount of food, enzymes and bile for the entire digestion process. The
aim of this pH-test adjustment experiment is to measure and record the amounts of HCl and NaOH
used to reach the target pH in order to perform more efficient pH adjustments when running the
digestion protocol. These volumes are indicative of the necessary volume of acids and bases needed
for the gastric and intestinal phases. Note that, for solid food, the pH changes are generally slower in
response to addition of HCl or NaOH. It is important to remain patient and wait long enough for the
pH to become stable; this may take >5 min, depending on food particle size and buffering capacity.
If one intends to take samples at different time points during digestion, it is recommended to
prepare one tube per time point, e.g., prepare six digestion tubes for six time points. As most foods are
heterogeneous mixtures during digestion, sampling is more reproducible by starting digestion with
individual tubes per time point. If the food sample has special requirements in terms of nutrient
stability (e.g., light sensitivity, oxidation), the characteristics of the tubes should be adapted to these
particular situations (e.g., opaque tubes, maintenance of the food samples on ice). The end volume
of the digest should be calculated in advance in order to use the most suitable reaction vessel
(e.g., 50-mL tubes) to allow proper mixing during all digestion phases.
Optionally, a replicate test tube (stability test tube) can be prepared to evaluate food stability
during exposure to simulated digestive fluids without enzymes or bile, for example, after the oral,
gastric and intestinal phases. It can also be advisable to prepare an enzyme-blank tube, i.e., a digestion
tube with all enzymes and bile but without food. This may be helpful in identifying enzyme, bile salts
or degradation products thereof during analysis of the digests. It is important to highlight that owing
to proteolytic enzyme autolysis, especially that of pepsin, enzyme-derived peptides can be detected in
digesta, which can be easily monitored with this blank-enzyme tube.
Intestinal phase, stop reaction and readout
The intestinal phase of the protocol starts with the mixing of the gastric chyme with the same volume
of the pre-warmed SIF. The pH is adjusted with the amount of NaOH previously calculated in the
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pH-test adjustment experiment. In this phase, two different options are given, (i) the use of pan-
creatin and (ii) the use of individual enzymes: porcine trypsin (100 U/mL), bovine chymotrypsin
(25 U/mL), porcine pancreatic α-amylase (200 U/mL), porcine pancreatic lipase (2,000 U/mL) and
porcine pancreatic colipase in molar excess to lipase. The amount of pancreatin to be used in the
intestinal phase of digestion is based on trypsin activity to achieve 100 U/mL in the final mixture.
This calculation may result in low lipase activity for high-fat-containing foods or if fat digestion is the
aim of the study. In this case, it is recommended to include additional lipase to obtain 2,000 U/mL of
lipase activity in the final mixture and colipase in a molar ratio of 2:1 (colipase to lipase), which
corresponds approximately to a mass ratio of 1:2 (colipase to lipase). Because this will require the
measurement of the lipase activity in the pancreatic extract and in the lipase preparation, the use of
individual enzymes could be the preferred option. Similarly, because the activity of amylase in
pancreatin can vary between batches and the activity can be too low to digest starch-rich foods, the
use of individual enzymes could also be a good option when following carbohydrate digestion. Bile
salts are added to the intestinal mixture to reach 10 mM in the final mixture, after determination of
the bile salt concentration in the commercial product (Enzyme assays). There are several commercial
options for bile salts, but bovine bile is preferred because its composition is similar to that of human
bile64. Bile solubilization requires exhaustive mixing, which can be achieved, for instance, in a rotating
wheel mixer at 37 °C for 30 min.
In vitro digestion is carried out for a wide range of purposes and with different endpoints. In all
cases, sampling, sample preservation and the post treatment of samples after food digestion are
critical, and some adaptations could be needed depending on the particular requirements of each
experiment (Table 1). For example, to stop pepsin activity, the pH of gastric samples must be raised to
7.0, either by the addition of 1 M sodium bicarbonate or 1 N NaOH solution. The pH shift after the
gastric phase is very effective in stopping pepsin activity and similar to in vivo conditions found in the
duodenum56. If the pH increase is not desired, the use of pepstatin A, a highly selective inhibitor of
aspartyl proteases such as pepsin (inhibition constant Ki = 0.1 nM), has also been suggested
68. When
gastric digestion is considered as an endpoint, sample snap freezing in liquid nitrogen followed by
freeze-drying is recommended. Raising the pH to 7.0 strongly reduces the activity of gastric lipase on
long-chain triglycerides58–60. Alternatively, the use of Orlistat (tetrahydrolipstatin) is
also recommended (gastric lipase half-inhibition time of <1 min) to block gastric lipolysis61.
Add Orlistat at a final concentration of 0.6 mg/mL (1 mM) to obtain an inhibitor to lipase molar
ratio of 1,000, taking into account that the gastric lipase activity of 60 U/mL corresponds to 50 µg/mL
or 1 µM lipase.
After gastrointestinal digestion and in order to inhibit the different enzymatic activities of the
digested samples, immediate snap freezing after sampling is necessary. However, when thawing the
sample for subsequent analysis, residual enzymatic activities could substantially affect the stability of
the samples. Therefore, addition of sufficient amounts of enzyme inhibitors against target digestive
enzymes is strongly recommended. In the case of proteases, the addition of 5 mM Pefabloc SC (4-(2-
aminoethyl) benzenesulfonyl fluoride hydrochloride), with the ability to irreversibly inhibit trypsin
and chymotrypsin, is recommended due to its lower toxicity in comparison with phe-
nylmethylsulfonyl fluoride40. Alternatively, the use of Bowman–Birk inhibitor (BBI) from soybean, a
potent inhibitor of both trypsin and chymotrypsin that has Ki values at the nanomolar level, has
also been recommended62. To inhibit lipolysis by pancreatic lipase, the use of 5 mM
4-bromophenylboronic acid has been reported69. Inhibition of pancreatic lipase by Orlistat is too slow
(half-inhibition time >5 min) to be used here61. For amylase inhibition heat-shock treatment,
inactivation by ethanol or inhibition with 12% (wt/vol) trichloroacetic acid (TCA) has been used64,
depending on the downstream sample analysis. Once the target inhibition occurs, the digests should
be immediately snap frozen in liquid nitrogen and freeze-dried.
When biological activity of digested samples has been evaluated, heat-shock treatment (in boiling
water for 5 min) to irreversibly inactivate proteases can also be considered28. However, it should be
noted that heat treatment is detrimental to the food structure, to proteins in particular, as heat
treatment generally causes irreversible denaturation and aggregation. For cell culture assays, consider
whether the use of Pefabloc or other enzyme inhibitors can affect the readout of the experiment, and
whether the osmolarity must be corrected by dilution to physiological values (285–300 mOsm/kg
H2O, pH 7–7.5) in order to avoid cell osmotic shock. Other combined procedures for removal or
enrichment of certain food components, such as defatting, centrifugation, dialysis, filtration and
size-exclusion chromatography, are also commonly used.
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Materials
Reagents
● Ultrapure type I water, generated by a Milli-Q system or similar (referred to in the text as ‘water’)
● Human salivary α-amylase (Sigma-Aldrich, cat. no. 1031)
● Porcine pepsin (Sigma-Aldrich, cat. no. P7012 or P6887)
● Rabbit gastric extract for gastric lipase (see ‘Use of lipase in the gastric phase’ section above; Lipolytech,
cat. no. RGE 25-100MG) c CRITICAL Rabbit gastric extract contains both gastric lipase and pepsin.
● Bovine bile (Sigma-Aldrich, cat. no. B3883, preferred option because composition is closest to that in
humans); alternatively, porcine bile (Sigma-Aldrich, cat. no. B8631) can be used
● Porcine pancreatin (Sigma-Aldrich, cat. no. P7545) or individual intestinal porcine enzymes (trypsin,
chymotrypsin, amylase, lipase and colipase; see ‘Reagents for optional protocol with individual
enzymes’ below)
● CaCl2(H2O)2 (Merck, cat. no. 2382)
● NaOH (Merck, cat. no. 9141) ! CAUTION NaOH is corrosive and causes severe skin burns and eye
damage. Use proper personal protective equipment.
● HCl (J. T. Baker, cat. no. 6081) ! CAUTION HCl is corrosive, causes burns and is irritating to
the respiratory system. Use proper personal protective equipment and work in a fume hood while
handling it.
● KCl (Merck, cat. no. 4936)
● KH2PO4 (J. T. Baker, cat. no. 0240)
● NaHCO3 (Merck, cat. no. 6329)
● NaCl (Merck, cat. no. 6404)
● MgCl2(H2O)6 (Merck, cat. no. 5833)
● (NH4)2CO3 (Sigma-Aldrich, cat. no. 207861)
● CaCl2 (H2O)2 (Sigma-Aldrich, cat. no. C3881)
● Amyloglucosidase (Sigma-Adrich, cat. no. A1602)
● Tris–HCl buffer (Sigma-Aldrich, cat. no. T3251)
● 3,5-Dinitrosalicyclic acid (Sigma-Adrich, cat. no. D0550)
● Sodium potassium tartrate (Sigma-Aldrich, cat. no. 1551140)
Enzyme inhibitors options (see Experimental design and Table 1)
● Pefabloc SC (4-(2-aminoethyl)benenesulfonyl fluoride; Sigma-Aldrich, cat. no. 76307) ! CAUTION
Pefabloc SC is corrosive. Use proper personal protective equipment.
● Pepstatin A (Sigma-Aldrich, cat. no. P5318)
● Bowman–Birk inhibitor (BBI; Sigma-Aldrich, cat. no. T9777)
● 4-Bromophenylboronic acid (Sigma-Aldrich, cat. no. B75956) ! CAUTION 4-Bromophenylboronic acid
is hazardous and corrosive, causes eye damage and is harmful to the respiratory system. Use proper
personal protective equipment and work in a fume hood while handling it.
Chemicals for pepsin activity assay
● Hemoglobin from bovine blood (Sigma-Aldrich, cat. no. H6525-25G)
● Trichloroacetic acid (TCA; Sigma-Aldrich, cat. no. T6399-5G) ! CAUTION Trichloroacetic acid is
corrosive and causes severe burns to skin and eyes. It is soluble in water with release of heat. Use
proper personal protective equipment.
Chemicals for gastric lipase activity assay
● Taurodeoxycholate (Sigma-Aldrich, cat. no. T0875-1G)
● Tributyrin (≥99% (vol/vol); Sigma-Aldrich, cat. no. T8626)
● Bovine serum albumin (≥98% (wt/wt); Sigma-Aldrich, cat. no. A7030)
Chemical for trypsin activity assay
● p-Toluene-sulfonyl-L-arginine methyl ester (TAME; Sigma-Aldrich, cat. no. T4626-5G)
Chemicals for amylase activity assay
● Maltose standard (Sigma-Aldrich, cat. no. M5885-100G)
● Soluble potato starch (Sigma-Aldrich, cat. no. S5651-500G)
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● 3,5-Dinitrosalicylic acid (DNS; Sigma-Aldrich, cat. no. D0550-10G) ! CAUTION DNS is harmful if
swallowed and causes acute oral toxicity.
Chemical for chymotrypsin activity assay
● N-benzoyl-L-tyrosine ethyl ester (BTEE; Sigma-Aldrich, cat. no. B6125-5G)
Chemicals for pancreatic lipase activity assay
● Sodium taurodeoxycholate (Sigma-Aldrich, cat. no. T0875-1G)
● Tributyrin (Sigma-Aldrich, cat. no. W222305-1KG)
Chemical for bile acid determination
● Bile Acid Assay Kit (Sigma-Aldrich, cat. no. MAK 309) or ECOLINE Acides Biliaires (DiaSys, cat. no.
122129990313) or equivalent assay
Reagents for optional protocol with individual enzymes
● Porcine trypsin (Sigma-Aldrich, cat. no. T0303)
● Bovine chymotrypsin (Sigma-Aldrich, cat. no. C7762)
● Porcine pancreatic α-amylase (Sigma-Aldrich, cat. no. A3176)
● Porcine pancreatic lipase (Sigma-Aldrich, cat. no. L3126)
● Porcine pancreatic colipase (Sigma-Aldrich, cat. no. C3028)
Food (for further examples, see ‘Anticipated results’ section)
● Skim milk powder (SMP; low-heat, organic, protein= 42.34%, fat = 0.89% and lactose = 49.8%
(wt/wt); Fonterra)28
Equipment
● Standard laboratory centrifuge (suitable for 50-mL tubes, 5,000g; Heraeus Megafuge 40R; Thermo
Fisher, model no. 75004519)
● Standard laboratory vortex (Genius 3, IKA; HuberLab, model no. 17.1377.01)
● Standard laboratory pH meter (827 pH lab; Metrohm, model no. 2.827.0214)
● pH electrode designed for food systems (SenTix HWD, WTW, model no. X-103731)
● Overhead shaker/rotator (small volume, up to 50 mL; Rotator SB Stuart; Huberlab, model no.
17.0014.02)
● Incubator large enough to hold the above rotator, adjustable to 37 °C (Termaks; Labtec, model. no. B9000)
● Electric or manual mincer (Eddingtons Mincer Pro; Amazon, model no. 86001)
● Eppendorf tubes (2 mL; VWR, model no. 211-2120)
● Plastic centrifuge tubes (15 and 50 mL; VWR, cat nos. 391-3450 and 525-0399)
● Micropipettes and tips (Gilson P10-P1000; VWR)
● Volumetric flasks for solutions
● Glass beakers
Reagent setup
Simulated digestion fluids
Minimum volumes of stock solutions needed for the preparation of 400 mL of simulated digestion
fluid at a 1.25× concentration:
● 0.5 mL of CaCl2(H2O)2 (0.3 M)
● 30 mL of KCl (0.5 M)
● 6 mL of KH2PO4 (0.5 M)
● 65 mL of NaHCO3 (1 M)
● 25 mL of NaCl (2 M)
● 2 mL of MgCl2(H2O)6 (0.15 M)
● 2 mL of (NH4)2CO3 (0.5 M)
● 1 M NaOH and 1 M HCl (a minimum of ~5 mL): for pH adjustment of stock solutions of simulated
digestion fluids
Stock solutions can be prepared and stored in aliquots at −20 °C for 1 year.
Simulated digestion fluids for the oral (SSF), gastric (SGF) and intestinal (SIF) digestion phases are
mixed at a 1.25× concentration using the electrolyte stock solutions and water according to Table 3
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and can be stored at −20 °C for 1 year. c CRITICAL CaCl2(H2O)2 should be added immediately before
the digestion experiment to avoid precipitation during storage. c CRITICAL All the volumes (Table 3)
are calculated for 400 mL of a 1.25× concentrated storage solution; just before use, they are mixed with
the necessary quantities of enzyme and finally diluted to a 1× concentration working solution (i.e., 4
parts of electrolyte solution + 1 part consisting of enzymes and water results in a 1× concentration of
the digestion fluids). c CRITICAL Simulated digestion fluids (1.25× concentrates) can be stored at
−20 °C for 1 year in small aliquots of appropriate size; e.g., for the experiment shown in Box 1, using 5 g
of food, at least 48 mL of SSF, 88 mL of SGF and 96 mL of SIF are needed. c CRITICAL Dilute enzymes
in cold solutions and keep them on ice until used. This will keep enzyme activity to a minimum.
c CRITICAL Pre-warm electrolyte solutions (SSF, SGF and SIF) to 37 °C before using them in the
digestion procedures.
Procedure
Preparation of reagents and digestion tubes ● Timing 4–5 d for all assays
1 Perform all enzyme and bile assays (Box 1) according to the protocols in the Supplementary
Information for each new batch of enzymes or after prolonged storage.
c CRITICAL STEP For the pepsin assay, dissolve pepsin in 10 mM Tris, 150 mM NaCl, pH 6.5,
which improves the reproducibility of the assay (Supplementary Method).
c CRITICAL STEP Spreadsheets for the enzyme assays and the volumes for the digestion procedure
are provided in Supplementary Data 1 and 2. In addition, online spreadsheets are available at http://
www.proteomics.ch/IVD and on the INFOGEST website at https://www.cost-infogest.eu/.
c CRITICAL STEP Prepare one tube per time point and food; e.g., for one food and six time points,
prepare six tubes.
? TROUBLESHOOTING
2 Pre-warm the electrolyte stock solutions at 37 °C, initially only SSF, SGF and SIF.
3 Prepare all enzyme and bile solutions immediately before the digestion experiment.
c CRITICAL STEP Keep all enzyme solutions on ice.
4 To perform more efficient pH adjustments during the digestive phases, prepare one replicate tube
(pH-test adjustment experiment) with the relevant amount of food, enzymes and bile for the entire
digestion process (time-lagged before the digestion experiment or 1 d before the digestion
experiment) and measure and record the volumes of HCl and NaOH used to reach the target pH.
These volumes are indicative of the necessary volume of acids and bases needed for the gastric and
intestinal phases.
5 (Optional) Prepare one replicate test as a food stability control to assess the behavior of the food
during exposure to simulated digestive fluids without enzymes or bile, for example, after the oral,
gastric and intestinal phases.
Table 3 | Volumes of electrolyte stock solutions of digestion fluids for a volume of 400 mL diluted with water
(1.25× concentrations)
SSF (pH 7) SGF (pH 3) SIF (pH 7)
Salt solution
added
Stock
concentrations
Milliliters of
stock added
to prepare
0.4 L (1.25×)
Final salt
concentration
in SSF
Milliliters of
stock added
to prepare
0.4 L (1.25×)
Final salt
concentration
in SGF
Milliliters of
stock added
to prepare
0.4 L (1.25×)
Final salt
concentration
in SIF
(g/L) (M) (mL) (mM) (mL) (mM) (mL) (mM)
KCl 37.3 0.5 15.1 15.1 6.9 6.9 6.8 6.8
KH2PO4 68 0.5 3.7 3.7 0.9 0.9 0.8 0.8
NaHCO3
a 84 1 6.8 13.6 12.5 25 42.5 85
NaCl 117 2 – – 11.8 47.2 9.6 38.4
MgCl2(H2O)6 30.5 0.15 0.5 0.15 0.4 0.12 1.1 0.33
(NH4)2CO3* 48 0.5 0.06 0.06 0.5 0.5 – –
HCl 6 0.09 1.1 1.3 15.6 0.7 8.4
CaCl2(H2O)2
b 44.1 0.3 0.025 1.5 0.005 0.15 0.04 0.6
aThe use of carbonate salts in the electrolyte solutions requires the use of sealed containers with limited headspace, see also CRITICAL STEP in Step 24. bCaCl2(H2O)2 should be added
immediately before use. Volumes in Table 2 are indicated for a typical experiment of 5 mL of SSF.
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6 Prepare one replicate test tube as a blank for digestion without food (replaced by water) but
with all required enzymes and bile. See videos of enzyme assays (Supplementary Videos 3–7),
as well as the digestion procedures (Supplementary Videos 1 and 2). Videos are also available online
on the YouTube channel ‘In vitro food digestion - COST action INFOGEST’, https://www.youtube.
com/channel/UCdc-NPx9kTDGyH_kZCgpQWg, and on the INFOGEST website, https://www.
cost-infogest.eu/.
Digestion procedure ● Timing 5–8 h
7 Oral phase (30 min). Dilute food with SSF at a ratio of 1:1 (wt/wt) to achieve a swallowable bolus
with a paste-like consistency similar to that of tomato paste or mustard at the end of the oral phase.
If the consistency of the bolus is thicker than such a paste, add water to achieve the proper
consistency. Salivary amylase is needed only to digest starch-containing food. It can be omitted if
the food does not contain starch. Do not use lower-purity salivary amylase or pancreatic amylase.
8 Mix food with SSF to achieve a final ratio of 1:1 (wt/wt), e.g., 5 g of food to 5 g of SSF.
9 Measure the volume of the final digestion mixture of the food + SSF mixture. Record this volume,
as it will be used in Step 17.
10 If necessary, simulate mastication by mincing the food in an electric or manual mincer.
11 Depending on the food (e.g., bread), mincing can be done together with the SSF electrolyte
(without enzymes).
12 Add SSF electrolyte stock solution to the food, if not done in the previous step.
13 Add CaCl2(H2O)2 in order to achieve a total concentration of 1.5 mM in SSF.
14 Add the salivary amylase, if necessary, prepared in water to achieve an activity of 75 U/mL in the
final mixture.
15 Add the remaining water in order to achieve a 1× concentration of the SSF.
16 Incubate while mixing for 2 min at 37 °C.
c CRITICAL STEP Electrolyte concentrations are given for the simulated digestive fluids (SSF, SGF
and SIF), and accumulation in consecutive digestion phases is not considered; enzyme activities are
expressed as units per milliliter in the final digestion mixture.
17 Gastric phase (2–3 h). Pre-warm the SGF electrolyte stock solution at 37 °C. Add SGF electrolyte
stock solution to the oral bolus to achieve a final ratio of 1:1 (vol/vol).
18 Adjust the pH to 3.0 by adding a defined volume of HCl previously determined during a pH-test
adjustment experiment, see ‘Experimental design’.
c CRITICAL STEP For solid food, the pH changes are generally slower in response to the addition of
HCl; it is important to remain patient and wait until the pH is stable; this usually takes >5 min,
depending on food particle size and buffering capacity.
19 Add CaCl2(H2O)2 solution in order to achieve a final concentration of 0.15 mM in SGF.
20 Add the porcine pepsin solution prepared in water to achieve an activity of 2,000 U/mL in the final
digestion mixture.
21 Add the gastric lipase solution prepared in water to achieve an activity of 60 U/mL in the final
digestion mixture.
22 Verify the pH and adjust to 3.0 if necessary.
23 Add water in order to achieve a 1× concentration of SGF.
24 Incubate the samples at 37 °C, mixing the digestive mixture sufficiently (e.g., rotating wheel,
shaking incubator) for 2 h from the point at which pepsin was added. If there are large precipitates
or clogs form, see the ‘Troubleshooting’ section.
c CRITICAL STEP Rabbit gastric extracts contain both gastric lipase and pepsin67. The pepsin
activity in RGE must be determined and taken into account together with the porcine pepsin to
reach a combined pepsin activity of 2,000 U/mL in the final digestion mixture.
c CRITICAL STEP The use of carbonate salts in the electrolyte solutions requires that sealed
containers with limited headspace be used. In open vessels, CO2 will be released and the pH will
progressively increase with time. If open vessels are used, such as when using the ‘pH-stat’ approach
or for sampling purposes, we suggest replacing the sodium bicarbonate (NaHCO3), the main source
of carbonates, with NaCl at the same molar ratio in order to maintain the ionic strength of the
electrolyte solutions (oral, gastric and intestinal). Such adjustments have already proven effective
in avoiding unwanted pH drift in open vessels in both the gastric70 and intestinal42 phases of
digestion (Table 3).
? TROUBLESHOOTING
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25 Intestinal phase (2–3 h). Pre-warm the SIF electrolyte stock solution in a 37 °C water bath. Add SIF
electrolyte to the gastric chyme to achieve a final ratio of 1:1 (vol/vol).
26 Adjust the pH to 7.0 by adding a defined volume of NaOH previously determined during a pH-test
adjustment experiment, see ‘Experimental design’.
c CRITICAL STEP For solid food, the pH changes are slower in response to the addition of NaOH;
see remarks in Step 18; this may take several minutes.
27 Add the bile solution to the SIF/gastric chime solution in order to reach a final concentration of 10
mM. Place the solution in a rotating wheel mixer at 37 °C for at least 30 min to achieve complete
bile solubilization.
28 Add CaCl2(H2O)2 solution in order to reach a concentration of 0.6 mM in SIF.
29 Perform the intestinal phase with pancreatin (option A) or with individual enzymes (option B).
(A) Pancreatin
(i) Add the pancreatin suspension in SIF solution to achieve a trypsin activity of 100 U/mL
in the final mixture. Additional pancreatic lipase may be needed for the digestion of
fat-containing food to reach the required lipase activity to achieve a lipase activity of
2,000 U/mL in the final mixture.
c CRITICAL STEP Measure trypsin activity in pancreatic lipase powder and subtract it
from the needed trypsin activity.
(B) Individual enzymes
(i) Add trypsin, chymotrypsin, pancreatic α-amylase, pancreatic lipase and the colipase
solutions in SIF in order to reach 100, 25, 200 and 2,000 U/mL and colipase at a molar
excess (ratio of 2:1 colipase:lipase), respectively, in the final digestion mixture.
30 Verify the pH and adjust to 7.0 if necessary.
31 Add water in order to achieve a 1× concentration of the SIF.
32 Incubate the samples at 37 °C, using a rotating wheel or shaking incubator to mix the digestive
mixture sufficiently for 2 h, starting at the point when pancreatic enzymes were added. For
difficulties with sampling, see the ‘Troubleshooting’ section.
c CRITICAL STEP If open vessels are used (‘pH-stat’ approach), NaHCO3 should be replaced with
NaCl in the electrolyte solutions to avoid unwanted pH drift (Step 24, CRITICAL STEP note).
? TROUBLESHOOTING
Troubleshooting
Troubleshooting advice can be found in Table 4.
Table 4 | Troubleshooting table
Step Problem Possible reason Solution
1 (enzyme activity) Pepsin activity results in a
lower amount of activity
units than specified
Enzyme activity
measurement performed
incorrectly
Follow the standardized procedure, using
hemoglobin as substrate. Dissolve pepsin in 10 mM
Tris, 150 mM NaCl, pH 6.5
Amylase activity very low DNS (3,5-dinitrosalicylic
acid) does not react with the
product
DNS solution must be freshly prepared
24 (gastric phase) Food is not digested as
expected. It forms a big clog
and it is not digested at the
end of the gastric phase
Excessive amount of
substrate
Revise the amount of food introduced into the
system. Realistic food consumption should be
targeted. Dilute or suspend food in an appropriate
amount of water, if necessary. For example, to mimic
the porcine in vivo digestion of cheese29 at the end
of the gastric phase, the cheese must be diluted with
water at a 1:2 (wt/wt) ratio before the oral phase
It is difficult to adjust the pH
during gastric digestion
Quick pH drift during the
gastric phase
Run a pH-test adjustment experiment with the same
food to determine volumes and times for HCl
addition
24, 32 (gastric/
intestinal phases)
Difficulties taking a
homogeneous sample during
digestion
Presence of different phases
(lipids, water and solids)
Use individual sample tubes for each time point
rather than withdrawal of samples from the
digestion vessel
Table continued
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Timing
Step 1, enzyme activity and bile assays: ~4 d for all assays
Steps 2 and 3, preparation of solutions: 2 h
Step 4, pH-adjustment experiment: 5 h (time-lagged before the digestion experiment)
Steps 5 and 6, preparation of replicate tests as control: 20 min
Steps 7–32, whole digestion experiment: 5–8 h, depending on number of food samples and time points;
e.g., one food sample and five time points takes ~5 h; two food samples and five time points (two gastric
and three intestinal points) takes ~8 h
Steps 7–16, oral phase: 30 min
Steps 17–24, gastric phase: 2–3 h
Steps 25–32, intestinal phase: 2–3 h
Anticipated results
Protein digestion
Without standardized digestion methods, the main difficulties in the field of food digestion were the
absence of comparable results from different laboratories and the lack of physiological relevance of
experimental data. The INFOGEST method was tested with respect to these two aspects, focusing on
protein digestion.
The robustness of the protocol and comparability of experimental data were assessed in several
inter-laboratory trials in which the participants were asked to digest a standardized SMP by applying
their existing in-house protocols first, and then by using the harmonized protocol28. The first critical
step in protein hydrolysis is assessment of the pepsin activity in the gastric phase. The heterogeneous
pattern observed with the in-house digestion protocols (Fig. 2a, gastric phase) was improved sub-
stantially by the correct implementation of the harmonized protocol (Fig. 2b, gastric phase), except
for in laboratories 6 and 7, which showed incomplete casein hydrolysis. Adjustments in the pepsin
assay (addition of Tris buffer, see Step 1 CRITICAL STEP note and Box 1) improved the reprodu-
cibility and reduced lab-to-lab variability28. This improved pepsin assay is now recommended for the
INFOGEST 2.0 method. Figure 2b shows improved homogeneity between samples, as related to the
gastric phase, when the harmonized protocol was applied. Increased protein degradation in
the intestinal phase was observed in laboratories 4 and 7. Subsequent recommendations for correct
sample preparation, in particular the correct inhibition of enzymes at the end of the digestion
experiment (Table 1), improved lab-to-lab variability28.
Table 4 (continued)
Step Problem Possible reason Solution
Poor mixing during digestion Tube shape, volume or
shaking is insufficient
Check the volume of the sample and the tube or vials
to allow sufficient mixing of the sample
32 (intestinal
phase)
Intestinal samples affect cell
viability in cell culture
studies
Presence of bile salts,
enzyme inhibitors
Avoid the use of enzyme inhibitors to stop the
digestion reaction. Reduce the bile salt concentration
during the intestinal phase. Sufficiently dilute the
digestion mixture
Presence of insoluble
material at the end of the
intestinal phase
Non-digestible material Use an individual sample tube for each time point
Poor lipid digestion at the
end of digestion
Food contains a high amount
of lipids
Add porcine pancreatic lipase and colipase to
achieve 2,000 U/mL lipase activity in the final
mixture. Consider additional trypsin activity present
in the pancreatic lipase
Starch digestion is too low Incorrect method was used
for quantification of starch
digestion products
Add amyloglucosidase to samples before measuring
glucose or use a reducing sugar assay to measure
starch digestion products. Check the activity of the
amylase
Starch digestion product
concentration does not
change over time
Starch digestion is
completed before the
samples are collected
Take more samples at earlier time points. Consider
using less amylase to slow the reaction. Check the
feasibility of results by expressing findings as
percentages of starch digested
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Physiological relevance of the protocol was evaluated by comparing in vitro SMP digestion with
that of an in vivo pig trial29. Pigs were fed reconstituted SMP from the same batch as that applied in
the in vitro tests, and samples were collected from the stomachs and in several sections of the small
intestine (jejunum, I1–I3 to ileum, I4) after sacrifice. Milk peptides were identified with mass spec-
trometry, and overall peptide patterns were visualized by summing the number of times each indi-
vidual amino acid was identified within a milk peptide. Overlay of the average peptide patterns for
αs2-casein from the harmonized in vitro digestion (n = 7) and in vivo pig digestion (n = 8) showed
that at the end of the gastric phase, the peptide pattern corresponded well to that of the pig sample
collected from the stomach; the peptide pattern in the in vitro intestinal phase sample was most
similar to that of the pig sample collected in the median jejunum (I3). This comparison showed that
protein hydrolysis at the endpoints of the harmonized INFOGEST digestion method was in
agreement with that of the in vivo digestion (Fig. 3).
In conclusion, both inter-laboratory comparability and physiological relevance were improved by
the correct application of the harmonized in vitro digestion protocol.
Lipid digestion
To date, most published digestion experiments using this INFOGEST method did not include a
gastric lipase because of the lack of commercially available, acceptable substitutes for HGL. This
situation changed with the availability of RGEs containing gastric lipase; see ‘Use of lipase in the
gastric phase’ in the ‘Experimental design’ section. Both HGL and rabbit gastric lipases exhibit, at the
recommended gastric pH of 3.0, ~50% of their maximum activity measured at pH 4–5.471,72.
Moreover, the in vitro gastric lipolysis of infant formula by rabbit gastric lipase was consistent with
in vivo data, with the degree of lipolysis reaching 10% after 60 min of gastric digestion73. These data
therefore suggest that gastric lipolysis could be studied using this INFOGEST 2.0 method with RGE as
a source of gastric lipase64 or HGL, if available61.
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Fig. 2 | Protein separation by gel electrophoresis of in vitro–digested skim milk powder. a,b, Comparison of results from
in-house protocols performed in individual laboratories 1–12 (a), with the harmonized protocol, performed in seven
different laboratories (b), after the gastric and the intestinal phases of in vitro digestion. Undigested SMP is shown as a
control; specific protein bands are highlighted with arrows: Casein fragments, partly hydrolyzed casein; pancreatin, bands
originating from pancreatin. M, molecular weight marker; SMP, skim milk powder. Adapted from Egger et al.28 under a
Creative Commons Attribution 4.0 license (https://creativecommons.org/licenses/by/4.0/legalcode).
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The INFOGEST method has also been used to study intestinal lipid digestion, for example, in oil-
in-water emulsions stabilized by milk or soya lecithin74. However, human gastric analog and phos-
pholipase A2 (PLA2) were added in this procedure. The degree of hydrolysis (percentage of TAG
disappearance) ranged between 73% and 87% (±5%) at the end of the intestinal phase (120 min). In
addition, in vitro digestion was also performed with more complex systems, such as whole-fat dairy
products or protein/polysaccharide emulsions. Depending on the structure of the food matrix and the
state of dispersion of the lipids, the reported degrees of hydrolysis at the end of the intestinal phase
ranged from moderate (66% of remaining lipids in poorly digestible raw oat flakes due to limiting
matrix structure)75 to an almost complete disappearance of triglycerides76.
Intestinal lipid digestion can be assessed by chemical analyses of collected samples. The protocol
recommends analyzing the entire volume of digestive tubes to prevent sampling errors (see Step 1,
CRITICAL STEP note, one tube per time point and food). This precaution is particularly useful in the
presence of lipids75, as they often tend to destabilize and phase-separate (cream) during the gastric
and/or intestinal phases of digestion. If aliquots are taken as sample points, great care should be taken
to represent the whole digested solution. The best way to analyze the extent of lipolysis is to conduct
Folch extractions77 on the samples in the presence of internal standards before the analysis of
classes of the lipids (residual triglycerides, free fatty acids, diglycerides and monoglycerides) by
thin-layer chromatography combined with densitometry or gas chromatography with a flame
ionization detector (GC-FID)78 or HPLC coupled to a light-scattering detector79. Free fatty acids can
also be quantified after solid-phase extraction with GC-FID, using fatty acids as internal stan-
dards73,80. The pH-stat method, one of the most commonly used methods for monitoring pancreatic
lipolysis, can also be used, but three sources of errors should be taken into consideration: (i) the pH-
stat measurements can be impaired by the high concentrations of carbonate salts recommended for
the simulated digestion fluids (Step 24, CRITICAL STEP note); it is therefore advised to replace
NaHCO3 salts with NaCl at the same molarity in all electrolyte solutions (oral, gastric and intestinal)
when planning to use pH-stat experiments during the intestinal phase of digestion42; (ii) protein
hydrolysis also contributes to the pH-stat signal in the intestinal conditions (pH = 7), meaning that
this approach is suitable for studying pancreatic lipolysis only when the contribution of proteins is
either neglected or subtracted42; and (iii) some fatty acids, especially long-chain fatty acids, are not
ionized at pH 7. A back titration at pH 9.0 should be performed to measure all the free fatty
acids released81.
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Fig. 3 | Comparison of in vitro–digested skim milk powder peptide patterns of κ-casein with in vivo (pig) digestion. a, Gastric in vitro digestion
samples (in vitro S) were compared to gastric pig samples (pig S, n = 8, as previously published by Egger et al.29, approval no. 2015_04_FR;26115).
b, Intestinal in vitro digestion samples were compared to pig sampling sections collected along the digestive tube from duodenum (D), proximal
jejunum intestinal section 1 (I1), median jejunum (I2), distal jejunum (I3) and ileum (I4)29. The x axis shows the amino acid sequence (one-letter code)
of κ-casein, and the y axis shows the number of times each amino acid was identified within a κ-casein peptide of ≥5 amino acids. Adapted with
permission from Egger et al.28, Elsevier.
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Digestion of starch
The structure of starch in a ready-to-eat plant-based food is a function of a multitude of
factors. These include its botanical origin, growing conditions, processing, food preparation
(mainly cooking) and storage. These all have a major impact on salivary and pancreatic amylase-
catalyzed starch digestion. The rate of the loss of starch and the appearance of the digestion products
(maltose and maltooligosaccharides) are the most common measures of in vitro starch digestibility.
To help in the understanding of the physiological effects of starch digestion, such as on glycemic
response in humans, measurements should also include (i) the accurate dose and nature of the starch
in the food as eaten; (ii) the characterization of the food matrix (microstructure, macro-
and micronutrient composition) and (iii) a measure of the degree of starch gelatinization
and/or retrogradation.
It is recommended that starch amylolysis be quantified only in the intestinal phase by measuring
the appearance of the starch digestion products over time, e.g., the concentration of reducing sugars
in the liquid phase. Salivary amylase will have a minor impact on starch digestion in the static model,
where the gastric pH is instantaneously adjusted to 3. After terminating amylase activity by mixing
the sample with four volumes of ethanol (final concentration = 80% (wt/vol)), for example (see
different options in Table 1), undigested starch is often separated from digested starch by cen-
trifugation. Analysis of reducing sugar concentration in the supernatant is often done with common
colorimetric assays (e.g., using DNS or PAHBAH (4-hydroxybenzhydrazide) reagents). Another more
common method is to treat an aliquot of the amylase digestion products from the 80% (wt/vol)
ethanol supernatant with buffered amyloglucosidase to convert all amylase digestion products to
glucose. Glucose can then be determined through a whole host of methods, including colorimetric
and enzymatic assays (e.g., D-glucose assay kit) or by direct chromatography analysis, to name just a
few. The data collected can then be used as input variables to a wide variety of simple to complex
kinetic-based mathematical models that seek to quantify starch digestion and give predictions on the
physiological effects of the food.
Bioaccessibility of phytochemicals
The main challenges for investigating common dietary phytochemicals such as hydrophilic poly-
phenols and hydrophobic carotenoids are (i) the physiological appropriateness of the digestion
conditions, such as reproducible matrix release and the sufficient presence of enzymes required for
cleavage and cellular uptake and (ii) separation of the bioaccessible phase from unavailable phyto-
chemicals (e.g., precipitated or in complexed form), which can be achieved by centrifugation and/or
filtration/dialysis.
Good correlations between bioaccessibility and in vivo bioavailability have been obtained for
certain phytochemicals, such as carotenoids82,83. However, slight alterations of the digestion para-
meters suggested by the original INFOGEST method27 can markedly influence bioaccessibility. For
instance, increasing the amount of pancreatin and/or bile84 or increasing the speed of shaking/stirring
can considerably enhance the bioaccessibility of carotenoids by improving mixing, disrupting oil
droplets and increasing micellization. Thus, careful consideration and the possible further standar-
dization of these parameters are vital. Additional important factors to consider are light and oxygen,
as they can result in the oxidative degradation of carotenoids85 and polyphenols86, as well as poly-
merization, of the latter87. It is recommended to flush samples with Ar or N2 for a few minutes before
small intestinal digestion to remove oxygen83,88 or to use pyrogallol. However, the latter is unsuitable
for polyphenolic samples, as it is a potential metabolite. Another often-neglected factor is the
potential effect of brush-border membrane (BBM) enzymes (e.g., lactase–phlorizin–hydrolase) on
phytochemical bioaccessibility, especially for polyphenols89,90. The inclusion of BBM vesicles in
in vitro gastrointestinal digestion may increase the physiological relevance of the model, especially for
polyphenols91. However, BBMs are not commercially available nor is there any standard method
available to date.
For polyphenols, dialysis is often performed to remove macromolecular-bound compounds92, but
for carotenoids, a combination of centrifugation (e.g., 4,000g for at least 30 min at room temperature)
and a filtration step (0.2 µm) has become the most widely used method31 to separate the bioaccessible
aqueous phase from larger lipid droplets or crystals that would not be taken up by the enterocytes.
When combining in vitro digestion with cellular assays (e.g., cellular uptake/transport), the toxicity
of the bile salts must be accounted for, by including a cleanup step, e.g., solid-phase extraction93–95,
or at least the sufficient dilution of samples (e.g., 4× dilution).
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Finally, it should be considered that the colon may play an important role for the bioavailable
fraction. Although it is well known that polyphenols can undergo many changes in the colon89, and
may be absorbable in the colon, little is known about carotenoids, although a significant fraction
would be bioaccessible in the colon96.
Ongoing developments and future perspectives for in vitro food digestion
The establishment of the INFOGEST digestion protocol is a good starting point in the standardi-
zation and harmonization of food digestion methods. Henceforth, results from different research
groups can be compared in a meaningful manner. However, users must be aware of the shortcomings
of this method, and considerable efforts are being made around the world to improve or add to the
existing method.
The INFOGEST method is for adult digestion only. However, there is a strong need to apply this
method to specific human population groups, the most important being infants and the elderly, but
also adolescents and patients with cystic fibrosis or gastric bypass surgery, to name but a few. A recent
review97 summarizes the existing literature and provides some recommendations on experimental
digestion parameters, with the INFOGEST method being the starting point for all other methods.
Although static methods can be useful, they can be inadequate for simulation of the dynamic
processes during digestion (e.g., pH gradients, gradual addition of enzymes and gastric fluid, con-
tinuous gastric emptying). As mentioned earlier, various dynamic digestion methods6–10 account for
some of these factors. A low-cost semi-dynamic method based on equivalent in vivo data from the
digestion of dairy products was recently developed49 and described in detail50. International
INFOGEST members are currently working on a consensus method.
Enzymes from the small intestinal BBMs are recognized as playing a major role in the activation of
trypsinogen (enterokinase) and the further degradation of proteins/peptides and carbohydrates, as
well as improving the bioaccessibility of phytochemicals. The use of brush-border enzymes falls into
the gray area between bioaccessibility (potentially absorbable) and bioavailability (available at the site
of action), and, to date, it is not clear how they should be applied. BBMs of animal origin have
recently been included in static digestion methods39,98,99 and can provide physiologically consistent
information100. However, to date, BBM enzymes are not commercially available and are extracted
from fresh animal intestines101 or used as intestinal extracts. There is still a lack of reliable infor-
mation on the correct enzymatic activities, enzyme/substrate ratio and diversity of enzymes, which
further limits the use of BBM in standardized digestion methods at the moment. However, given the
importance of BBMs in the digestive process, further progress in terms of defining digestive
parameters is anticipated.
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